Pharmacy Practice Specialty Residency Program (PGY2)
About the PGY2 Residency Program
The Department of Pharmacy Services at Children’s Hospital of Philadelphia offers a one-year post-graduate year 2 (PGY2) Pharmacy Practice Specialty Residency in Pediatrics. The purpose of the residency is to cultivate future leaders in pediatric specialty practice.
Pharmacists completing this residency will master the principles of pediatric pharmacotherapy and be competent and confident pediatric practitioners capable of providing direct patient care in various pediatric subspecialties. They will understand the principles of a sound pediatric pharmacy operational system and be able to integrate these principles into their clinical practice.
These pharmacists will be skilled in educating other healthcare professionals, patients, and the community on pediatric medication-related issues and will be capable of conducting basic clinical research to answer medication-related questions in the pediatric population. They will demonstrate professional maturity by following a personal philosophy of practice, monitoring their own performance, exhibiting commitment to the profession, and exercising leadership in improving the safety of the medication use system.
The residency program is designed using the American Society of Health-System Pharmacists (ASHP) Residency Standards, and utilizes the goals and objectives designed within this program.
For more information please see handbook and policies »
Required and elective learning experiences
To facilitate the goals of the residency program the resident will complete the following required learning experiences: Hospital Pharmacy (Orientation/Onboarding/Training), Drug Information (Longitudinal), On-Call (Longitudinal), Medication Safety / Regulatory Compliance (Longitudinal), Acute Care, Cardiac Intensive Care Unit, Neonatal/Infant Intensive Care Unit, Pediatric Intensive Care Unit, Oncology, Solid Organ Transplantation, Educational Module Development and Delivery, Recruitment (Longitudinal), and Teaching (Longitudinal). Elective learning experiences include: Acute Care II, Infectious Diseases, Informatics, Oncology II, Research, and development of experiences in areas specific to the resident's interest.
The PGY2 Pediatric Pharmacy resident will also be required to complete at least 1 longitudinal patient care focused learning experience over the course of the residency year, including options in Cardiac Anticoagulation Immersion Program and Endocrinology Clinics, though others may be developed based on the resident's interest and preceptor availability.
Additional requirements of the PGY2 Pediatric Pharmacy resident include activities pertaining to, or exercises in drug use evaluations, formulary management, reporting of medication safety events or adverse drug reactions, learning experience presentations, journal clubs, educational presentation, student precepting / didactic teaching, participation in multidisciplinary committees, recruitment activities and research.
The resident provides a service commitment to the hospital in the form of staffing and clinical on-call service (alternating) of approximately one weekend per three weeks.
The resident will attend the ASHP Midyear Clinical Meeting in December and an associated specialty meeting (e.g. PPAG) in the spring of their residency year. The resident is also encouraged to attend local pharmacy meetings as well.
Stipend and benefits
- $50,500 per year
- Paid Personal Leave (25 days, includes vacation and sick days)
- Seven holidays (resident will work one of these holidays)
- Hospital Benefits Program — medical, dental, vision, prescription, disability, life insurance, medical and dependent care reimbursement accounts, 403b plans
To apply for the Pharmacy Practice Specialty Residency Program, you must:
- Be a graduate of an accredited Doctor of Pharmacy Degree Program
- Have successfully completed a Pharmacy Practice Residency (PGY1)
- Be eligible for licensure in the state of Pennsylvania by October 1 of residency year. Please refer to the PA State Board of Pharmacy for licensure information.
Selection of the resident is based on evaluation of college transcripts, letters of recommendation and a full day, on-site interview. Applicants will be contacted by mid-February to either schedule an on-site interview or to be informed that their application has been declined.
How to apply
The Children's Hospital of Philadelphia Pharmacy Practice Specialty Residency Program uses the Pharmacy Online Residency Centralized Application Service (PhORCAS) for all required materials. Please visit the PhORCAS website to submit all necessary materials.
It is strongly encouraged that the three reference forms required in the PhORCAS application be submitted by a clinical preceptor, a faculty member and your PGY1 Residency Program director. It is also recommended that the required references include narrative comments in the PhORCAS reference form.
In addition to the required application materials in PhORCAS, please upload a current picture in the supplemental information section.
The application deadline is January 2.
Tobacco-free hiring policy
To help preserve and improve the health of our patients, their families and our employees, Children’s Hospital of Philadelphia has a tobacco-free hiring policy. This policy applies to all candidates for employment (other than those with regularly scheduled hours in New Jersey) for all positions, including those covered by the Collective Bargaining Agreement.
Job applicants who apply after July 1, 2014 will be expected to sign an attestation stating they’ve been free of nicotine or tobacco products in any form for the prior thirty (30) days. They will also undergo a cotinine test as a part of the Occupational Health pre-placement drug screen administered after the offer of employment has been accepted but before the first day of hire.
Exemptions: Attending physicians (excluding CHOP physicians in the Care Network), psychologists, principal investigators and/or Penn-based faculty are exempt from this process to better align with our colleagues at the University of Pennsylvania Perelman School of Medicine.